Petra Pharma Corp — Form D

Petra Pharma Corp of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2018-09-13. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
Steve GillisDirectorNew York, NY
Steve GillisRelated PersonNew York, NY
Brian O'CallaghanRelated PersonNew York, NY
THONG LEDirectorSeattle, WA
THONG LEExecutive OfficerSeattle, WA
THONG LEPromoterSeattle, WA
THONG LERelated PersonSeattle, WA
LINDSAY RAYLERelated PersonNew York, NY
Asish XavierDirectorSouth San Francisco, CA
Paul SekhriRelated PersonNew York, NY
M. Johnston ErwinDirectorNew York, NY
M. Johnston ErwinRelated PersonNew York, NY
David SchubertRelated PersonNew York, NY
Barbara Johnston DaltonDirectorNew York, NY
Jenna Johnston FogerDirectorNew York, NY
Paul Johnston SekhriDirectorNew York, NY
David Johnston McElligottExecutive OfficerNew York, NY
David Johnston McElligottPromoterNew York, NY
David Johnston RenasExecutive OfficerNew York, NY
Albert Johnston YuExecutive OfficerNew York, NY
Albert Johnston YuPromoterNew York, NY
Lindsay Johnston RayleExecutive OfficerNew York, NY
Lindsay Johnston RaylePromoterNew York, NY
David Johnston SchubertExecutive OfficerNew York, NY
David Johnston SchubertPromoterNew York, NY

Other filings by this issuer (7)

FiledFormOfferingSold
2020-03-31D/A$27.5M$27.5M
2019-10-21D/A$23.0M$20.0M
2019-08-01D/A$17.0M$17.0M
2019-04-26D/A$13.3M$13.3M
2018-01-22D/A$48.3M$31.2M
2017-01-04D/A$48.3M$21.2M
2016-01-06D$10.4M$10.0M

More